<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Dev Immunol</journal-id>
      <journal-title>Developmental Immunology</journal-title>
      <issn pub-type="ppub">1044-6672</issn>
      <publisher>
        <publisher-name>Hindawi Publishing Corporation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta><article-id pub-id-type="pmid">1320968</article-id><article-id pub-id-type="pmc">2275864</article-id>
        <article-id pub-id-type="pii">S1740252292298140</article-id>
        <article-id pub-id-type="doi">10.1155/1992/29814</article-id>
    <article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>TCR V <italic>&#x3B1;</italic>- and V <italic>&#xDF;</italic>-Gene Segment Use in T-Cell
Subcultures Derived from a Type-III Bare Lymphocyte
Syndrome Patient Deficient in MHC Class-II Expression</article-title></title-group><contrib-group>
        <contrib contrib-type="author"><name><surname>Lambert</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
        <contrib contrib-type="author"><name><surname>van Eggermond</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
        <contrib contrib-type="author"><name><surname>Mascart</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
        <contrib contrib-type="author"><name><surname>Dupont</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib>
        <contrib contrib-type="author" corresp="yes"><name><surname>van den Elsen</surname><given-names>P.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
    </contrib-group>
        <aff id="aff1"><label>1</label>
            <addr-line>Department of Immunohematology and Blood Bank</addr-line>
            <addr-line>University Hospital</addr-line>
            <addr-line>Leiden</addr-line>
            <addr-line>2300 RC</addr-line>
            <country>The Netherlands</country>
        </aff>
        <aff id="aff2"><label>2</label>
            <addr-line>Department of Immunohematology</addr-line>
            <addr-line>Hospital St. Pierre</addr-line>
            <addr-line>Brussels</addr-line>
            <country>Belgium</country>
        </aff>
        <aff id="aff3"><label>3</label>
            <addr-line>Department of Immunohematology</addr-line>
            <addr-line>Erasme Hospital</addr-line>
            <addr-line>Brussels</addr-line>
            <country>Belgium</country>
        </aff>
    <pub-date pub-type="ppub"><year>1992</year></pub-date><volume>2</volume><issue>3</issue><fpage>227</fpage><lpage>236</lpage><permissions><copyright-statement>Copyright &#xA9; 1992 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1992</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
        <p>Previously, we and others have shown that MHC class-II deficient humans have greatly
reduced numbers of CD4+CD8&#x2013; peripheral T cells. These type-III Bare Lymphocyte
Syndrome patients lack MHC class-II and have an impaired MHC class-I antigen
expression. In this study, we analyzed the impact of the MHC class-II deficient
environment on the TCR V-gene segment usage in this reduced CD4+CD8&#x2013; T-cell
subset. For these studies, we employed TcR V-region-specific monoclonal antibodies
(mAbs) and a semiquantitative PCR technique with V <italic>&#x3B1;</italic> and V <italic>&#xDF;</italic> amplimers, specific for
each of the most known V <italic>&#x3B1;</italic>- and V <italic>&#xDF;;</italic>-gene region families. The results of our studies
demonstrate that some of the V <italic>&#x3B1;</italic>-gene segments are used less frequent in the
CD4+CD8&#x2013; T-cell subset of the patient, whereas the majority of the TCR V <italic>&#x3B1;</italic>- and
V <italic>&#xDF;</italic>-gene segments investigated were used with similar frequencies in both subsets in the
type-III Bare Lymphocyte Syndrome patient compared to healthy control family
members. Interestingly, the frequency of TcR V <italic>&#x3B1;</italic>12 transcripts was greatly diminished
in the patient, both in the CD4+CD8&#x2013; as well as in the CD4&#x2013;CD8+ compartment,
whereas this gene segment could easily be detected in the healthy family controls. On
the basis of the results obtained in this study, it is concluded that within the reduced
CD4+CD8&#x2013; T-cell subset of this patient, most of the TCR V-gene segments tested for are
employed. However, a skewing in the usage frequency of some of the V <italic>&#x3B1;</italic>-gene segments
toward the CD4&#x2013;CD8+ T-cell subset was noticeable in the MHC class-II deficient patient
that differed from those observed in the healthy family controls.</p>
    </abstract><kwd-group>
        <kwd>Type-III Bare Lymphocyte Syndrome</kwd>
        <kwd>MHC class-II deficiency</kwd>
        <kwd>MHC class II</kwd>
        <kwd>T-cell selection</kwd>
        <kwd>T-cell repertoire</kwd>
        <kwd>TcR V-gene segment use</kwd>
    </kwd-group></article-meta>
  </front>
</article>
</pmc-articleset>
